https://www.selleckchem.com/products/msab.html
To evaluate the therapeutic value of melatonin, mesenchymal stem cells and their extracellular vesicles, exosomes, on renal ischemia-reperfusion. Female albino rats (n=64) were divided into eight groups (n=8 per group) control, sham (only laparotomy), renal ischemia-reperfusion (renal ischemia-reperfusion+phosphate-buffered saline), melatonin (renal ischemia-reperfusion+melatonin), mesenchymal stem cells (renal ischemia-reperfusion+mesenchymal stem cells), exosomes (renal ischemia-reperfusion+exosomes), melatonin+mesenchymal stem cells (re